---

Pharmacotherapy in Obesity

Full Text PDF Share on Facebook Share on Twitter

---

Review Article

Author Details : Sunil Chaudhry*

Volume : 5, Issue : 3, Year : 2020

Article Page : 110-117

https://doi.org/10.18231/j.ijcaap.2020.024

Suggest article by email

Get Permission

Abstract

Obesity is one of the most common medical problems in India and a risk factor for illnesses such as
hypertension, diabetes, degenerative arthritis, kidney disease and myocardial infarction. In India, more
than 135 million individuals were affected by obesity. According to ICMR INDIAB study 2015, prevalence
rate of obesity and central obesity are varies from 12% to 31% and 17%–36% respectively. Medications
are formulated to reduce energy intake, increase energy output or decrease the absorption of nutrients.
Drugs cannot replace diet, exercise and lifestyle modification, which remain the cornerstones of obesity, In
2014 the global economic impact of obesity was estimated to be US $2.0 trillion or 2.8% of the global
gross domestic product (GDP) treatment. Obesity also imposes costs in the form of lost productivity
and foregone economic growth as a result of lost work days, lower productivity at work, mortality and
permanent disability.

Keywords: Obesity, Body mass index, Drug therapy, Herbal drugs, Metabolic Syndrome.

How to cite : Chaudhry S , Pharmacotherapy in Obesity. IP Int J Compr Adv Pharmacol 2020;5(3):110-117

This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.